Just-Evotec Biologics Secures Gates Foundation Grant to Expand Global Access to Biotherapeutics
The funding will support ten new molecular design projects over three years, leveraging Just-Evotec Biologics’ J.MD computational platform to optimise monoclonal antibodies and other biologics, reduce development costs and improve access to affordable therapies for infectious diseases in low- and middle-income countries.
Immunogenicity | 12/01/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy